Clientèle Limited Overview
Clientèle is a mid-sized South African insurance group focused on the entry-level and lower-middle-income ("mass") market, where it sells simple, low-premium funeral, life, hospital, legal and savings products through direct and grassroots distribution: a large Independent Field Advertiser (IFA) network, telesales, agency kiosks, funeral-parlour intermediaries, a strategic affiliates channel and, since 2025, a micro-insurance adviser network serving social-grant recipients. Two acquisitions transformed its scale: 1Life Insurance (July 2024, settled in shares to Telesure Investment Holdings) and Emerald Life (June 2025, funded by R570m of preference shares). Group embedded value rose from R6.0bn (June 2024) to R10.3bn (December 2025). Persistently thin trading and a share price discount to embedded value led the board to take the company private via a company-funded offer at 85% of escalated embedded value (R19.90 per share), with delisting on 30 June 2026. The group remains controlled by a concentrated block of strategic shareholders.
Company's own description
In its regulatory and directory descriptions the company characterises Clientèle Limited as the holding company of the group whose long-term insurance subsidiary, Clientèle Life, markets, distributes and underwrites insurance and investment products and invests the funds derived from them, accounting for the majority of group earnings and assets; the group also offers personal and business-lines legal insurance through Clientèle General Insurance, its non-life subsidiary (Profile's Stock Exchange Handbook 2026 Issue 2). The IAR 2025 frames the group purpose as "Safeguarding Your World with Compassion" and the vision as becoming South Africa's most reliable and valued financial services partner. The chairman's stated long-run objective is a group product "in every home" (IAR 2025).
Business model
Clientèle earns money principally as a risk insurer of small-premium, long-duration retail policies (funeral, life, hospital cash-type, legal cover). The economics rest on: (i) high-volume, low-cost acquisition through community-based and direct channels; (ii) persistency — keeping premium-paying policies on the books for many years, since acquisition costs are front-loaded; (iii) claims experience; (iv) expense control; and (v) investment returns on policyholder and shareholder assets. The managing director's stated success drivers, reported in the IAR 2025, are exactly these: positive client contact, new business volume and quality, motivated employees, treating clients well, claims experience, persistency, expenses and investment returns.
Supplementary earnings streams include:
- Single-premium investment business, including co-branded single-premium investment products underwritten for Old Mutual and Absa clients (FY2024 results), which generate fee and spread income and drive large swings in financial assets.
Revenue from contracts with customers: (R393.1m in FY2025): stand-alone Rewards (loyalty) contracts, IFA business-fee income, and deferred income on 1Life single-premium investment business.
Mobile services: (Clientèle Mobile: SIM cards, data and airtime).
Revenue model mix
Clientèle does not report a product-vs-service-vs-subscription split. Using IFRS 17 line items for FY2025: insurance revenue net of reinsurance of c.R3,286m (IAR 2025 seven-year chart) versus revenue from contracts with customers of R393.1m (FY2025 results). On that basis roughly 89% of the two combined is insurance revenue and 11% is fee/rewards/service revenue (derived; not a company-defined metric). Premiums are overwhelmingly recurring monthly (subscription-like) collected by debit order, payroll deduction or SASSA grant deduction.
Value-chain position
Clientèle is vertically integrated: it designs products, distributes them through owned or contracted channels, underwrites the risk on its own licences (Clientèle Life, 1Life, Emerald Life, Clientèle General), administers policies and claims, and manages assets via an external investment manager under a group investment committee (IAR 2025). Emerald Life also administers and distributes policies underwritten by a third party, Lion of Africa Life Assurance (GroundUp, April 2026). 1Life historically relied on outsourced services from Telesure Group Services, which continued under amended agreements after the acquisition (1Life terms announcement, 3 November 2023).
Customer types and end-markets
- Low- and lower-middle-income South African households (LSM 1–8 per the group's consumer education reporting), largely black South Africans.
Social grant recipients: (SASSA old-age pension and disability grant beneficiaries) — a core segment for Emerald Life and 1Life.
Government employees: (Emerald Life).
-
Members of affiliated organisations and intermediaries (Strategic Affiliates Channel; funeral parlours).
-
Bank customers of co-branding partners (single-premium investments).
-
Small businesses (business-lines legal insurance).
Independent characterisation
Clientèle is best understood as a distribution-led mass-market risk insurer whose competitive moat is a low-cost, trust-based, community sales network rather than balance-sheet scale. Before 2024 it was a slow-growing, high-payout cash generator whose embedded value barely moved between FY2019 and FY2024 (R6.6bn to R6.0bn) because persistency pressure and debit-order disruption offset new business. The 1Life and Emerald deals nearly doubled embedded value and shifted the mix toward funeral micro-insurance for SASSA beneficiaries, a segment that is profitable but concentrated and politically sensitive. Post-delisting, it is effectively a privately controlled insurer with a minority of residual outside shareholders.
Strategy
Stated strategic themes (IAR 2025; FY2025 and interim results)
Treating Clients Well (TCW): positioned as going beyond regulatory Treating Customers Fairly, with simple products, plain-language wording and empathetic claims handling.
"Shared value": investment in the Clientèle App, Clientèle Rewards, Clientèle Royalty, 1Lifestyle and Clientèle Mobile to deliver tangible value during the life of the policy, not only at claim.
Integration and synergy: the 1Life and Emerald integrations were described in March 2026 as "tracking ahead of plan", with synergies in distribution optimisation, product development and removal of duplicated costs (1Life operating expenses fell R28.1m period-on-period in H1 FY2026).
Persistency management: initiatives to reduce withdrawals in a disrupted collections environment.
Product differentiation: explicitly framed as a response to banks, retailers and telcos entering the market with data advantages.
Township economy: focus on serving clients in township economic activity.
Multi-brand strategy: the group intends to keep and grow all brands (Clientèle, 1Life, Emerald), led by client brand preference.
Mission: to be South Africa's most valued and trusted financial services partner.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description |
|---|---|---|
| Emerald Life acquisition | Announced 1 Nov 2024; effective 24 Jun 2025 | Entry into SASSA-linked micro-insurance with c.360,000 policies |
| 1Lifestyle | Jan 2025 | Loyalty programme for 1Life clients |
| 1Life campus consolidation | H1 FY2025 | Operations moved to Clientèle Campus |
| Campus renovation and extension | FY2025 | Capacity for enlarged group |
| Strategic Affiliates Channel growth | FY2025 | Partnering with large-membership organisations; growing number of affiliates and books |
| Maize-meal voucher in loyalty programmes | Post Dec 2025 | Staple-food benefit added to Royalty-type programmes |
| BEE ownership restoration | Apr–Jun 2026 | AEI specific issue to lift black shareholding back above 10% after 1Life dilution |
| Delisting and management co-investment | Apr–Jun 2026 | Removal of listing costs and price-discount distraction; management equity alignment |
| Remaining-shareholder liquidity put | From 30 Jun 2028 for 10 years | Annual two-week window to put shares to Clientèle Life at 85% of latest published EV, capped at R50m per year in aggregate (excludes the concert group) |
| ESG/operational | Ongoing | Solar panels across the office park, water harvesting; YES youth employment programme (350+ youth over three years) |
Medium-term financial targets
Clientèle does not publish quantitative medium-term targets or earnings guidance. The board's risk appetite uses three metrics: financial soundness (prudential minimum plus buffer), free cash flow (management-accounts cash profits less dividends) and REVE (IAR 2025). Business objectives are set on a three-year horizon by each entity.
Products & Services
Pricing, product launch years and specifications are generally not publicly disclosed in the filings reviewed; where unknown this is stated.
Clientèle Life (long-term insurance)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Funeral plans | Individual and family funeral cover | Mass-market households | Core product; also written via funeral-parlour intermediaries since FY2022 |
| Life cover | Entry-level life risk cover | Mass market | Pricing not disclosed |
| Hospital plans | Hospital cash/benefit cover | Mass market | Listed among products (TradingView, Investing.com profiles) |
| Estate preservation | Estate-related cover | Mass to lower-middle income | Not detailed |
| Premium Savings / investment products | Recurring-premium savings | Mass market | Investment returns reported in net investment result |
| Single-premium investment products (co-branded) | Single-premium investment products underwritten for Old Mutual and Absa clients | Bank/partner clients | Planned portfolio maturity reduced financial assets by R4.1bn in FY2024; IPF tax assessed loss utilisation linked to this book |
| Credit life / wealth | Listed in third-party profiles | Not detailed | — |
1Life Insurance (RF) Limited (long-term insurance)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Underwritten direct life cover | Directly sold, underwritten life insurance | Middle market | 1Life began operating in 2006 as a direct life insurer |
| Intermediated life and funeral | Funeral and life via intermediaries, including TIH tied agents | Mass market | Cost-sharing agreement with TIH/Telesure for tied-agent sales |
| SASSA-linked funeral | Funeral cover paid by deduction from SASSA grants | Pensioners, disability-grant recipients | 166,636 pensioner policyholders plus 28,384 disability-grant policyholders (R3.72m/month) per March 2026 parliamentary data |
| Single Premium Investment business | Deferred-income investment product | Investors | Source of revenue from contracts with customers |
| 1Lifestyle | Loyalty programme mirroring Clientèle Royalty | 1Life policyholders | Launched January 2025 |
| Truth about Money | Financial literacy, legal (free wills, estate mediation), debt management | Previously disadvantaged communities | Established 2014; 79,671 completions to date (IAR 2025) |
Emerald Life (Pty) Ltd (life micro-insurance)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Micro-insurance funeral policies | Affordable funeral cover sold through a national adviser network (18 branches) | SASSA grant recipients and government employees | c.360,000 active policyholders at acquisition (Business Day, 9 Sep 2025); 241,178 pensioner policyholders averaging R169.67/month and 50,397 disability-grant policyholders (R9.06m/month) per March 2026 data |
| Third-party administered funeral | Administers and distributes funeral policies underwritten by Lion of Africa Life Assurance | Same | GroundUp, Apr 2026 |
Clientèle General Insurance (non-life)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Personal legal insurance ("Clientèle Legal") | Legal advice and cost cover | Individuals | Core non-life product |
| Business-lines legal insurance | Legal cover for small businesses | SMEs | Disclosed in Profile handbook |
| Domestic plan | Listed in third-party profile (TradingView) | Households | — |
CBC Rewards, Clientèle Mobile and Direct Rewards (non-insurance)
| Offering | Description | Launch | Notes |
|---|---|---|---|
| Clientèle Rewards (stand-alone Rewards product) | Paid loyalty/benefit contracts giving access to retailer and service-provider benefits | Pre-FY2021 | Book doubled in FY2024; described by management as highly successful |
| Clientèle Royalty | Loyalty scheme rewarding persistent policyholders | February 2024 | Group reports over R300m shared with loyal clients since launch, exceeding R25m per month (IAR 2025) |
| Maize-meal voucher | Added to group loyalty programmes after December 2025 | H2 FY2026 | Early adoption described as better than expected (interim results) |
| Rider Rewards | Rewards programme | — | Referenced in FY2024 results |
| Clientèle Mobile | SIM cards, airtime and data for clients | — | Integrated with rewards |
| Clientèle App | Sales capture, basic policy administration, access to Rewards and Mobile; self-service | c.FY2020–FY2021 | Used by clients and agents |
Distribution channels (service delivery)
IFA network (commission-based independent field advertisers, recruited largely from the communities served); telesales; agency kiosks in shopping centres; walk-in centres; funeral-parlour intermediaries; Strategic Affiliates Channel (organisations with large memberships); Emerald adviser branches; TIH tied agents for 1Life. The chairman identified Telesales and Agency as underperforming channels requiring intense management focus (IAR 2025).
Financial Narrative
Applicability note. As an insurer reporting under IFRS 17 and embedded value (EV), Clientèle does not report gross profit, operating income in the industrial sense, EBITDA, capex in a meaningful form, or a cash conversion cycle. These metrics are recorded as "not reported / not meaningful". The core value metrics for this business are headline earnings, total comprehensive income, EV, value of new business (VNB), recurring EV earnings (REVE) and recurring return on EV (RRoEV).
Earnings and per-share data
Sources: SENS results FY2021, FY2022 (originally published), FY2024 (FY2023 restated), FY2025; IAR 2025 seven-year table.
IFRS 17 operating line items
Sources: FY2024 and FY2025 results; IAR 2025.
Insurance revenue values are read from the IAR 2025 seven-year chart. Under IFRS 4 the group reported net insurance premiums of R2.17bn (FY2021) and R2.18bn (FY2022); these are not comparable with IFRS 17 insurance revenue. Profile's handbook reports "Total Income" of R2,640m (FY2022), R3,054m (FY2023), R2,133m (FY2024) and R4,366m (FY2025) on its own standardised basis.
Drivers. FY2024: insurance service result +4% as lower contractual service margin (CSM) release from a shrinking Clientèle Life book was offset by better claims; investment result doubled on higher single-premium income and returns; tax rose sharply from R28.1m because the prior year benefited from a R120m deferred-tax revision. FY2025: insurance service result +167%, driven by fewer onerous contracts at Clientèle (+R98.8m), 1Life consolidation (+R42.2m) and a R145.9m group CSM recognition on 1Life; investment result -33% on maturities and higher IPF tax liability; operating expenses +31% from 1Life costs (R111.3m), R13.4m intangible amortisation and once-off integration and Emerald acquisition costs.
Embedded value metrics
Sources: SENS results FY2021–FY2025; IAR 2025.
FY2025 RDR of 13.2% applies to the group excluding 1Life (1Life: 13.9%). At 31 December 2025, RDRs were 12.0% (Clientèle), 12.1% (1Life) and 11.3% (Emerald Life).
Growth rates (derived): EV CAGR FY2021–FY2025 12.1%; EV per share CAGR 4.0% (dilution from 117.8m shares issued for 1Life); headline earnings CAGR 13.7%; HEPS CAGR 5.7%; DPS CAGR 4.7%. Overall new business margin was 7.4% in FY2022 (10.2% excluding single premium), 4.8% in FY2023 and 9.0% in FY2024; FY2025 margin not located.
Commentary. EV per share was essentially flat between FY2021 and FY2023 because withdrawal losses (R217.3m in FY2022 alone), dividends of R370m–R420m per year and rising discount rates absorbed new-business value. The step-change in FY2025 reflects the 1Life acquisition (c.R2.1bn of EV at acquisition, for which Clientèle says it actually paid a R69m premium to EV despite the accounting "bargain purchase") and Emerald (R127.9m added at acquisition; EV R735.2m at 30 June 2025 versus R605.2m price).
Interim performance: H1 FY2026 vs H1 FY2025
Source: unaudited interim results, 2 March 2026 (H1 FY2025 figures restated).
Notes. H1 FY2025 EPS and net profit include the 1Life bargain purchase gain (originally R469.1m, later revised to R403.2m), explaining the EPS decline despite a 56.5% rise in headline earnings. H1 FY2025 HEPS was originally reported at 51.25c and EV per share at 1,844.61c; the 2026 interim release shows restated comparatives of 67.51c and 1,884.61c. No interim dividend was declared in either period (the group pays one annual dividend). Emerald contributed R49.5m of earnings, R123.9m of insurance service result, R61.1m VNB and R181.2m REVE before financing.
Balance sheet
Source: Profile's Stock Exchange Handbook 2026 Issue 2 (standardised; FY2022 and FY2023 restated). FY2021 standardised IFRS 17 data not available.
At 31 December 2025: ordinary shareholders' interest R7,152m, long-term liabilities R11,276m, capital employed R21,992m, NAV per share 1,578.96c.
Ratios
Source: Profile's Stock Exchange Handbook 2026 Issue 2, except the derived row.
Profile's "debt:equity" includes insurance and investment contract liabilities and is not a measure of borrowings. The company reported return on average shareholders' interest of 37% (FY2021) and 39% (FY2022) under IFRS 4, and 10.5% (FY2023 restated) and 10.0% (FY2024) under IFRS 17 — the drop reflects the R2.2bn IFRS 17 uplift in equity rather than a collapse in profitability. Regulatory solvency capital requirement (SCR) cover ratios under SAM were not located in the sources reviewed; the company repeatedly describes its solvency and liquidity position as sound. ROIC, interest coverage, asset turnover and cash conversion cycle: not reported / not meaningful for this insurer.
Cash flow and capital returns
In FY2026 the company also paid R419.8m (derived: 21,097,797 shares × R19.90, before 0.25% securities transfer tax) to repurchase shares under the delisting offer, partly funded by the R270.2m AEI subscription. The board warned that a maximum-acceptance outcome would have reduced the FY2026 dividend; actual acceptances (4.65%) were below the 8% cap. The FY2026 dividend, if any, was not publicly disclosed at the cut-off date.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net profit for the year (ZAR Mn) | 392.3 | 435.5 | 346.4 | 333.9 | 1,059.3 |
Headline earnings attributable (ZAR Mn) | 395.1 | 440.8 | 344.0 | 329.9 | 659.9 |
Total comprehensive income (ZAR Mn) | 383.9 | 413.6 | 336.9 | 492.4 | 1,604.2 |
EPS basic (ZAR cents) | 116.98 | 129.87 | 102.60 | 98.39 | 235.07 |
HEPS (ZAR cents) | 117.82 | 131.45 | 102.60 | 98.39 | 147.08 |
Dividend per share (ZAR cents) | 110 | 120 | 125 | 125 | 132 |
Total distributions declared (ZAR Mn) | 369 | 402 | 419 | 567 | 598 |
Dividend payout to HEPS (%) | 93.4 | 91.3 | 121.8 | 127.0 | 89.7 |
Income Statement
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Insurance revenue net of reinsurance (ZAR Mn) | 1,926 | 1,907 | 3,286 |
Total insurance service result (ZAR Mn) | 165.2 | 171.6 | 458.5 |
Total net investment result (ZAR Mn) | 124.8 | 254.9 | 170.2 |
Net insurance finance income (ZAR Mn) | 174.5 | 207.3 | 403.9 |
Revenue from contracts with customers (ZAR Mn) | 342.0 | 380.4 | 393.1 |
Operating expenses (ZAR Mn) | 418.8 | 420.7 | 551.2 |
Taxation charge (ZAR Mn) | 28.1 | 216.1 | 240.6 |
Key Financials and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Group embedded value (ZAR Mn) | 5,806.5 | 5,807.1 | 5,887.5 | 6,046.0 | 9,164.8 |
EV per share (ZAR cents) | 1,731.61 | 1,731.79 | 1,755.77 | 1,802.99 | 2,021.97 |
Value of new business (ZAR Mn) | 215.5 | 290.6 | 244.9 | 220.3 | 330.1 |
Recurring EV earnings (ZAR Mn) | 687.5 | 724.9 | 663.1 | 654.6 | 1,269.3 |
Recurring return on EV (%) | 12.4 | 13.3 | 12.3 | 12.0 | 16.8 |
Risk discount rate (%) | 12.1 | 13.8 | 14.1 | 14.3 | 13.2 |
Income Statement and Per-Share Data (H1FY2025–H1FY2026)
| Metric | H1FY2025 | H1FY2026 |
|---|---|---|
Net profit (ZAR Mn) | 704.7 | 474.3 |
Headline earnings attributable (ZAR Mn) | 299.9 | 469.3 |
EPS (ZAR cents) | 158.27 | 103.53 |
HEPS (ZAR cents) | 67.51 | 103.53 |
Net insurance service result (ZAR Mn) | 180.7 | 416.4 |
Net investment result (ZAR Mn) | 93.2 | 152.9 |
Net insurance finance income (ZAR Mn) | 197.9 | 204.7 |
Revenue from contracts with customers (ZAR Mn) | 178.2 | 217.5 |
Operating expenses (ZAR Mn) | 266.3 | 297.0 |
Taxation (ZAR Mn) | 88.6 | 209.6 |
Total comprehensive income (ZAR Mn) | 1,061.5 | 1,853.5 |
Embedded value (ZAR Mn) | 8,360.4 | 10,264.5 |
EV per share (ZAR cents) | 1,884.61 | 2,264.54 |
Value of new business (ZAR Mn) | 187.4 | 332.5 |
Recurring EV earnings (ZAR Mn) | 537.8 | 1,015.3 |
Annualised RRoEV (%) | 14.3 | 23.7 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Ordinary shareholders interest (ZAR Mn) | 3,275 | 3,209 | 3,277 | 5,905 |
Long-term liabilities (ZAR Mn) | 8,755 | 10,524 | 6,535 | 11,574 |
Capital employed (ZAR Mn) | 13,310 | 14,996 | 11,174 | 19,798 |
Fixed assets (ZAR Mn) | 456 | 468 | 490 | 609 |
Current assets (ZAR Mn) | 552 | 314 | 397 | 1,040 |
Current liabilities (ZAR Mn) | 140 | 166 | 117 | 277 |
NAV per share (ZAR cents) | 976.56 | 974.28 | 979.00 | 1,317.07 |
Margin Analysis (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Return on shareholders funds (%) | 13.30 | 10.79 | 10.17 | 17.93 |
Debt to equity (x) | 2.67 | 3.28 | 1.99 | 1.96 |
Solvency margin Profile definition (%) | 149.59 | 166.76 | 172.11 | 179.82 |
Payouts to premiums (x) | 0.20 | 0.91 | 0.91 | 0.86 |
Net profit to total income derived (%) | 16.5 | 11.3 | 15.7 | 24.3 |
Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Ordinary dividend paid during year (ZAR Mn) | 368.9 | 402.4 | 420.0 | 566.4 | 598.3 |
Revenue by Region (%)
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
South Africa share of group revenue derived (%) | 100 | 100 | 100 |
Share Price and Market Valuation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Share price at 30 June (ZAR) | 9.72 | 11.99 | 12.00 | 10.60 | 12.50 |
Market capitalisation at 30 June derived (ZAR Mn) | 3,259 | 4,020 | 4,024 | 3,555 | 5,666 |
Price to EV per share (x) | 0.56 | 0.69 | 0.68 | 0.59 | 0.62 |
Trailing price to HEPS (x) | 8.25 | 9.12 | 11.70 | 10.77 | 8.50 |
Dividend yield at 30 June price (%) | 11.3 | 10.0 | 10.4 | 11.8 | 10.6 |
Share Price
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Share price high (ZAR) | 12.40 | 13.35 | 14.50 | 14.41 |
Share price low (ZAR) | 7.90 | 9.20 | 9.50 | 10.01 |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (ZAR cents) | 110 | 120 | 125 | 125 | 132 |
Analyst Conclusions
Management guidance
Clientèle gives no numerical guidance. Its most recent outlook (2 March 2026) emphasised: continued focus on Treating Clients Well; 1Life and Emerald integration ahead of plan with identified synergies; continued investment in the App, Rewards, Royalty, 1Lifestyle and Mobile; early strong adoption of the maize-meal voucher; ongoing withdrawal-reduction initiatives; product differentiation; tight control environment; and optimism about growth over time in its target market.
Consensus expectations
None available (no sell-side coverage identified; company now unlisted).
Bull case
-
Acquisition earnings are compounding: RRoEV of 23.7% and VNB of R332.5m in H1 FY2026 (versus R187.4m) indicate the enlarged group is generating materially higher returns than the 12% achieved in FY2021–FY2024.
-
Cheap entry for remaining holders: at R19.90 the company was taken private at 0.88x interim EV, and EV per share grew 12% in the six months to December 2025 alone; if EV keeps growing, the 85%-of-EV put mechanism from 2028 locks in value accretion.
-
Niche dominance with structural demand: leadership in grant-deducted funeral cover (just over half of SASSA deduction premiums) in a country with 24m funeral-insured people and a vast life-protection gap.
Bear case
-
Persistency and collections remain structural problems: the group strengthened withdrawal assumptions in FY2025, and 1Life experienced withdrawal losses in H1 FY2026; debit-order system instability is outside management's control.
-
Regulatory and reputational concentration: dependence on SASSA beneficiaries and documented complaints about deductions create tail risk if the deduction framework is tightened.
-
Minority illiquidity and disclosure decline: remaining minorities face no market, an aggregate R50m annual put cap only from mid-2028, and reduced reporting obligations, while 92%+ is held by a concert group.
Catalysts and monitorables (next 12 months)
-
Publication of FY2026 annual financial statements or summary (post-delisting commitment), including EV per share at 30 June 2026 and any FY2026 dividend.
-
H1 FY2027 interim summary (expected c. early 2027).
-
Evidence of withdrawal and persistency improvement, especially at 1Life.
-
Emerald earn-out outcome (up to R50m tied to funeral policies written and collected over 24 months from closing).
-
Any regulatory change to SASSA grant-deduction rules or FSCA conduct action.
-
Further acquisitions, now unconstrained by the listed share price.
-
Board succession (Stott transition; Risk Committee chair change).
-
Management co-investment take-up and loan terms.
Analyst verdict
Clientèle has executed one of the more consequential transformations among South Africa's smaller insurers. For a decade, the business was a high-yield, low-growth cash machine: embedded value hovered near R6bn from FY2019 to FY2024 as persistency erosion, collection-system disruption and generous dividends offset new business. Two well-priced acquisitions changed the trajectory. 1Life was bought at roughly embedded value in scrip, bringing a strong SASSA franchise and a capable management team; Emerald was bought below its subsequently calculated EV, adding the largest single share of pensioner grant-deducted funeral premiums. The early integration evidence is encouraging: VNB nearly doubled and annualised recurring return on EV reached 23.7% in the first half of FY2026, while 1Life costs declined.
The decision to delist is rational given the facts disclosed: the shares traded at 0.56x–0.69x EV for five years, liquidity was below 1% of shares per year, and over 92% of the equity sat with strategic holders. The exit price of R19.90 was fair to sellers relative to market history (a 25% VWAP premium and the highest level in the share's recent record) but favourable to remaining owners relative to intrinsic value, given rapid EV growth. Only 4.65% of shares were tendered, a signal that most holders saw more value in staying.
The principal risks are not balance-sheet risks but franchise risks: persistency in a financially stretched client base, payment-system fragility, intensifying competition from data-rich banks such as Capitec, and the political sensitivity of insurance premiums deducted from social grants. Post-delisting, external visibility will fall sharply, so stakeholders should weight conduct outcomes and persistency data as heavily as headline embedded value.
Overall assessment: fundamentally improved, strategically well-positioned in its niche, now a privately controlled insurer whose value creation will be judged chiefly by embedded value per share growth and clean conduct in the grant-deduction market.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / appointment | Background and qualifications |
|---|---|---|---|
Gavin Quentin Routledge | Independent non-executive Chairman (chairs Clientèle Limited, Clientèle Life, Clientèle General, 1Life and Emerald boards) | Chairman since 31 Jan 2008 | BA, LLB; member of most board committees |
Basil William Reekie | Group Managing Director (executive) | Director since c.2008; CEO/MD since Oct 2012 per MarketScreener | BSc (Hons), FASSA; previously Managing Executive at QED Consulting |
Hugo Louw | Executive director; MD of Clientèle Life; appointed Deputy Group MD during FY2025 | Executive director since 1 Mar 2021; joined 2013 as Head of Operations | BCom (Hons), FASSA |
Angela Colleen Pillay | Group Executive Financial Director | Since 1 Apr 2024 | CA(SA), MCom; former FD of Sasfin Holdings; Head of Group Reporting at FirstRand Bank; former director of First National Bank Zambia |
Tshepisho (RDT) Zwane (formerly Tabane) | Executive director | Since 1 Mar 2021; joined Jan 2014 as HR Executive | BA, MPhil, MBA |
Barry Anthony Stott | Independent non-executive director | Since c.2010 | CA(SA); chaired Audit, Risk, Remuneration and Nominations committees; stepped off Clientèle General/1Life boards and Risk and Investment committees from 17 Feb 2026 in a phased transition |
Robert Donald Williams | Independent non-executive director | Since c.2013 | BBusSc (Hons), FASSA; designated to succeed Stott as Risk Committee chair |
Thetele Emmarancia Mashilwane | Independent non-executive director | Appointment date not confirmed | CA(SA), RA, MBA; chairs Social and Ethics Committee |
Herschel Philip Mayers | Independent non-executive director (per IAR 2025 and delisting announcement) | Appointment date not confirmed | BCom (Hons), FASSA |
Phethedi Gideon Nkadimeng | Non-independent non-executive director | Since c.2017 | BSc Statistics and Economics |
Gavin K. Chadwick | Non-independent non-executive director (formerly alternate to Dr ADT Enthoven) | Since c.2019 | MAgric, MBA |
Thomas John (Tom) Creamer | Non-independent non-executive director (TIH nominee) | Since 19 Jul 2024 | Certificate in Leadership for Senior Executives |
Murray A. Raisbeck | Alternate director to T Creamer (TIH nominee) | NED from 19 Jul 2024; alternate from 1 Jul 2025 | BSc (Hons) Agricultural Economics; CA (England and Wales) |
Ian M. Kirk | Non-executive director | Since 1 Jul 2025 | CA(SA); former CEO of Santam and Group CEO of Sanlam; boards include JSE Limited, Pepkor, Nutun, Netcare, SCOR (UK) and Shriram General Insurance (India) |
Executive Leadership Team
| Name | Role |
|---|---|
JL Potgieter | Head of the Actuarial Function and Group Chief Risk Officer |
B Frodsham | Group Strategic Operations Executive |
LA Botha | Group Marketing and Advertising Executive |
GK Kopeka | Group Executive; MD of Clientèle General from 1 Jul 2025 |
DT Habana | Group IT Executive |
TA (Tiffany-Ann) Boesch | Group Chief Operating Officer (interim Group CFO Nov 2023–Mar 2024; former Group CFO of PPS Insurance) |
M Thamanna | Group Strategy Executive |
LA (Laurence) Hillman | Managing Director, 1Life |
E van der Westhuizen; EC du Toit | Senior executives and directors of Emerald Life |
JWF Pretorius | Group Telesales Executive (resigned June 2025) |
Major Shareholders
| Holder | Stake | Basis / date |
|---|---|---|
Friedshelf 1577 (Pty) Ltd | 44.85% | Profile handbook, as at 30 Jun 2025 |
Telesure Investment Holdings (TIH) | c.26% at issue (117,815,756 consideration shares) | 1Life terms, Nov 2023; current exact holding not confirmed |
Hollard Group (Hollard Life Assurance, Hollard Insurance, Hollard Portfolio Management) | 14.43% | Profile, 30 Jun 2025 (down from 19.48% at 30 Jun 2024, consistent with dilution from the 1Life issue) |
Yellowwoods Trust Investments / Acacia Empowerment Investments (AEI), wholly owned by the Hollard Foundation Trust | 6.64% direct (c.8.39% including indirect, FY2025); plus 13,597,860 new shares issued 22 Jun 2026 | Profile; IAR 2025; SENS 30 Apr 2026 |
Arcadia Trust | Not disclosed individually | Part of 92.1% concert group |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Relative positioning (qualitative) |
|---|---|---|
Sanlam (Sanlam Retail Mass incl. Assupol, Safrican, Sanlam Developing Markets; Centriq via Santam) | Mass funeral and life; SASSA-deducted funeral | Largest rival in grant-deducted funeral; acquired Assupol Oct 2024; Clientèle and Sanlam clusters together collect c.87% of SASSA funeral deductions |
Old Mutual (Mass and Foundation cluster) | Mass funeral, savings | Largest tied distribution footprint; has reported a sustained drop in in-force funeral market share amid bank competition (Old Mutual Capital Markets Day 2025) |
Momentum Group (Metropolitan) | Mass funeral and life | Large mass-market life insurer |
Capitec Life | Funeral, credit life, life cover | Bank-led disruptor; reported covering 12m people for funeral and a 35% share of new funeral customers; began writing funeral on own licence after ending Sanlam arrangement |
Hollard | Funeral, life, partnership insurance | Also a major Clientèle shareholder (14.43%) |
AVBOB | Funeral (mutual) | Major funeral insurer and funeral services provider |
Absa Life / FNB Life / Standard Bank-Liberty | Bancassurance funeral and life | Data-advantaged bank channels (also partners via co-branded investments for Absa) |
Telesure Investment Holdings (Auto & General etc.) | Former owner of 1Life; bound by five-year non-compete on 1Life-competing products | Significant shareholder rather than competitor in life |
Retailers and telcos (insurance add-ons) | Funeral and simple life | Named by the chairman as competitors with superior client data |
Legal insurance providers (e.g., LegalWise and bank-linked legal plans) | Clientèle General legal plans | Not quantified |
Competitor Detail
| Metric | Clientèle |
|---|---|
FY2025 EV / group value | R9.16bn EV (Jun 2025); R10.26bn (Dec 2025) |
FY2025 VNB | R330.1m |
Headline earnings growth FY2025 | +100% (acquisition-driven) |



